Open access · CC-BY
via OpenAlex
Protective Effect of Nicotinamide Riboside on Glucocorticoid-Induced Glaucoma: Mitigating Mitochondrial Damage and Extracellular Matrix Deposition
Nan Zhang, Pengyu Zhang, Xizhi Deng, Min Zhu, Yixin Hu, Dongxiao Ji, Lufan Li, Yang Liu, Wen Zeng, Min Ke
Investigative Ophthalmology & Visual Science · 2024 · ▲ 11 citations
Abstract
Purpose: Glucocorticoid-induced glaucoma (GIG) is a prevalent complication associated with glucocorticoids (GCs), resulting in irreversible blindness. GIG is characterized by the abnormal deposition of extracellular matrix (ECM) in the trabecular meshwork (TM), elevation of intraocular pressure (IOP), and loss of retinal ganglion cells (RGCs). The objective of this study is to investigate the effects of nicotinamide riboside (NR) on TM in GIG. Methods: Primary human TM cells (pHTMs) and C57BL/6J mice responsive to GCs were utilized to establish in vitro and in vivo GIG models, respectively. The study assessed the expression of ECM-related proteins in TM and the functions of pHTMs to reflect the effects of NR. Mitochondrial morphology and function were also examined in the GIG cell model. GIG progression was monitored through IOP, RGCs, and mitochondrial morphology. Intracellular nicotinamide adenine dinucleotide (NAD+) levels of pHTMs were enzymatically assayed. Results: NR significantly prevented the expression of ECM-related proteins and alleviated dysfunction in pHTMs after dexamethasone treatment. Importantly, NR protected damaged ATP synthesis, preventing overexpression of mitochondrial reactive oxygen species (ROS), and also protect against decreased mitochondrial membrane potential induced by GCs in vitro. In the GIG mouse model, NR partially prevented the elevation of IOP and the loss of RGCs. Furthermore, NR effectively suppressed the excessive expression of ECM-associated proteins and mitigated mitochondrial damage in vivo. Conclusions: Based on the results, NR effectively enhances intracellular levels of NAD+, thereby mitigating abnormal ECM deposition and TM dysfunction in GIG by attenuating mitochondrial damage induced by GCs. Thus, NR has promising potential as a therapeutic candidate for GIG treatment.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1167/iovs.65.8.1
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Zhang, N., Zhang, P., Deng, X., Zhu, M., Hu, Y., Ji, D., Li, L., Liu, Y., Zeng, W., & Ke, M. (2024). Protective Effect of Nicotinamide Riboside on Glucocorticoid-Induced Glaucoma: Mitigating Mitochondrial Damage and Extracellular Matrix Deposition. <em>Investigative Ophthalmology & Visual Science</em>. https://doi.org/10.1167/iovs.65.8.1
Vancouver
Zhang N, Zhang P, Deng X, Zhu M, Hu Y, Ji D, et al. Protective Effect of Nicotinamide Riboside on Glucocorticoid-Induced Glaucoma: Mitigating Mitochondrial Damage and Extracellular Matrix Deposition. Investigative Ophthalmology & Visual Science. 2024. doi:10.1167/iovs.65.8.1.
BibTeX
@article{nan2024Protec,
title = {Protective Effect of Nicotinamide Riboside on Glucocorticoid-Induced Glaucoma: Mitigating Mitochondrial Damage and Extracellular Matrix Deposition},
author = {Nan Zhang and Pengyu Zhang and Xizhi Deng and Min Zhu and Yixin Hu and Dongxiao Ji and Lufan Li and Yang Liu and Wen Zeng and Min Ke},
journal = {Investigative Ophthalmology & Visual Science},
year = {2024},
doi = {10.1167/iovs.65.8.1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Ovarian Research 2025
Open access · CC-BY
Nicotinamide riboside supplementation ameliorates ovarian dysfunction in a PCOS mouse model
Movement Disorders 2021
Open access · CC-BY
Nicotinamide Riboside Improves Ataxia Scores and Immunoglobulin Levels in Ataxia Telangiectasia
Life Science Alliance 2023
Open access · CC-BY
Improving lysosomal ferroptosis with NMN administration protects against heart failure
bioRxiv (Cold Spring Harbor Laboratory) 2024
Preprint · CC-BY
Oral supplementation with Nicotinamide Riboside treatment protects RGCs in DBA/2J mouse model
Nutrients 2024
Open access · CC-BY
Effect of Nicotinamide Riboside Against the Exhaustion of CD8+ T Cells via Alleviating Mitochondrial Dysfunction
International Journal of Molecular Sciences 2022
Open access · CC-BY